Paul G. Pearson

4.1k total citations
97 papers, 2.9k citations indexed

About

Paul G. Pearson is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Paul G. Pearson has authored 97 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 23 papers in Pharmacology and 17 papers in Biochemistry. Recurrent topics in Paul G. Pearson's work include Pharmacogenetics and Drug Metabolism (18 papers), Sulfur Compounds in Biology (11 papers) and Drug Transport and Resistance Mechanisms (10 papers). Paul G. Pearson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Sulfur Compounds in Biology (11 papers) and Drug Transport and Resistance Mechanisms (10 papers). Paul G. Pearson collaborates with scholars based in United States, United Kingdom and Japan. Paul G. Pearson's co-authors include Thomas A. Baillie, Jiunn H. Lin, Yue Qiu, Bennett Ma, Thomayant Prueksaritanont, Sidney D. Nelson, J. Greg Slatter, Mohamed S. Rashed, Xiaojun Fang and Raju Subramanian and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Paul G. Pearson

93 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul G. Pearson United States	29	864	650	528	346	307	97	2.9k
Zheng Yang United States	36	1.3k 1.5×	334 0.5×	845 1.6×	160 0.5×	499 1.6×	107	3.5k
P. L. M. Jansen Netherlands	34	1.0k 1.2×	467 0.7×	1.7k 3.1×	898 2.6×	188 0.6×	79	3.8k
J. Greg Slatter United States	21	762 0.9×	540 0.8×	666 1.3×	95 0.3×	94 0.3×	50	1.9k
Roger Rahmani France	43	1.3k 1.5×	1.2k 1.8×	1.1k 2.1×	248 0.7×	93 0.3×	137	4.9k
Tsutomu Matsubara Japan	31	1.3k 1.6×	605 0.9×	733 1.4×	458 1.3×	56 0.2×	71	3.6k
John L. Gollan United States	34	1.4k 1.7×	288 0.4×	998 1.9×	761 2.2×	119 0.4×	108	6.1k
Mario Monshouwer Netherlands	35	683 0.8×	877 1.3×	770 1.5×	191 0.6×	96 0.3×	71	2.6k
Donald L. Hill United States	38	3.0k 3.5×	427 0.7×	821 1.6×	130 0.4×	211 0.7×	167	4.8k
Jerry M. Rice United States	33	1.4k 1.6×	331 0.5×	689 1.3×	176 0.5×	88 0.3×	124	3.8k
Yunhai Cui Germany	22	887 1.0×	807 1.2×	3.5k 6.5×	733 2.1×	452 1.5×	32	4.3k

Countries citing papers authored by Paul G. Pearson

Since Specialization

Citations

This map shows the geographic impact of Paul G. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Pearson more than expected).

Fields of papers citing papers by Paul G. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Pearson. The network helps show where Paul G. Pearson may publish in the future.

Co-authorship network of co-authors of Paul G. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Pearson. A scholar is included among the top collaborators of Paul G. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Pearson. Paul G. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rácz, Bóglárka, András Váradi, Paul G. Pearson, & Konstantin Petrukhin. (2020). Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey. PLoS ONE. 15(1). e0228291–e0228291. 7 indexed citations

Langlois, Daniel K., Michele C. Fritz, William D. Schall, et al.. (2018). ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome. BMC Endocrine Disorders. 18(1). 24–24. 19 indexed citations

Podoll, Terry, Paul G. Pearson, Jerry Evarts, et al.. (2018). Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metabolism and Disposition. 47(2). 145–154. 50 indexed citations

Sandhu, Punam, Wooin Lee, Xin Xu, et al.. (2005). HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN. Drug Metabolism and Disposition. 33(5). 676–682. 83 indexed citations

Sandhu, Punam, John S. Vogel, Mark J. Rose, et al.. (2004). EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE. Drug Metabolism and Disposition. 32(11). 1254–1259. 45 indexed citations

Kumar, Sanjeev, Gloria Y. Kwei, Grace K. Poon, et al.. (2003). Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1161–1171. 19 indexed citations

Prueksaritanont, Thomayant, Raju Subramanian, Xiaojun Fang, et al.. (2002). Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization. Drug Metabolism and Disposition. 30(5). 505–512. 276 indexed citations

Prueksaritanont, Thomayant, Jamie J. Zhao, Bennett Ma, et al.. (2002). Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1042–1051. 219 indexed citations

Wienkers, Larry C., Rick C. Steenwyk, P E Sanders, & Paul G. Pearson. (1996). Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 982–990. 37 indexed citations

10.

Fleishaker, Joseph C., Paul G. Pearson, Larry C. Wienkers, Laura Pearson, & Gary Peters. (1996). Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 991–998. 22 indexed citations

11.

Wienkers, Larry C., Rick C. Steenwyk, S. A. MIZSAK, & Paul G. Pearson. (1995). In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.. Drug Metabolism and Disposition. 23(3). 383–392. 19 indexed citations

12.

Slatter, J. Greg, et al.. (1991). Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chemical Research in Toxicology. 4(2). 157–161. 89 indexed citations

13.

Duncan, Mark W., Nelly E. Villacreses, Paul G. Pearson, et al.. (1991). 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.. Journal of Pharmacology and Experimental Therapeutics. 258(1). 27–35. 77 indexed citations

14.

Pearson, Paul G., et al.. (1991). Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcarbamoyl)cysteine, two electrophilic S-linked conjugates of methyl isocyanate. Chemical Research in Toxicology. 4(4). 436–444. 47 indexed citations

15.

Pearson, Paul G., et al.. (1990). S-(N-Methylcarbamoyl)glutathione: A reactive S-linked metabolite of methyl isocyanate. Biochemical and Biophysical Research Communications. 166(1). 245–250. 52 indexed citations

16.

Pearson, Paul G., Erik J. Søderlund, Erik Dybing, & Sidney D. Nelson. (1990). Metabolic activation of 1,2-dibromo-3-chloropropane: evidence for the formation of reactive episulfonium ion intermediates. Biochemistry. 29(20). 4971–4981. 38 indexed citations

17.

Pearson, Paul G., et al.. (1990). Chemical synthesis and cytotoxic properties of N-alkylcarbamic acid thioesters, metabolites of hepatotoxic formamides. Chemical Research in Toxicology. 3(2). 118–124. 17 indexed citations

18.

Pearson, Paul G., et al.. (1990). Metabolic activation of 1,2-dibromo-3-chloropropane to mutagenic metabolites: detection and mechanism of formation of (Z)- and (E)-2-chloro-3-(bromomethyl) oxirane. Chemical Research in Toxicology. 3(5). 458–466. 18 indexed citations

19.

Meerman, John H.N., et al.. (1989). Formation of cyclic 1,N2-propanodeoxyguanosine and thymidine adducts in the reaction of the mutagen 2-bromoacrolein with calf thymus DNA.. PubMed. 49(22). 6174–9. 16 indexed citations

20.

Baillie, Thomas A., Paul G. Pearson, Mohamed S. Rashed, & William N. Howald. (1989). The use of mass spectrometry in the study of chemically-reactive drug metabolises. Application of MS/MS and LC/MS to the analysis of glutathione- and related S-linked conjugates of N-methylformamide. Journal of Pharmaceutical and Biomedical Analysis. 7(12). 1351–1360. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact